Company: GMRE
Filing Date: 2025-11-14
Form Type: 424B5
Source: 0001104659-25-112543
Chunk: 67

Company: Global Medical REIT Inc.
Filing Date: 2025-11-14
Form: 424B5
Chunk 67
---
 of parity preferred stock upon which like voting rights
have been conferred and are exercisable).

So long as any shares of Series A Preferred Stock
remain outstanding, we will not, without the affirmative vote or written consent of the holders of at least two-thirds of the then outstanding
shares of Series A Preferred Stock and each other class or series of parity preferred stock with like voting rights (voting together as
a single class), authorize, create, issue or increase the number of authorized or issued shares of any class or series of equity shares
ranking senior to the Series A Preferred Stock with respect to rights of dividend payments and the distribution of assets upon any voluntary
or involuntary liquidation, dissolution or winding up of the Company, or reclassify any of our authorized equity shares into such equity
shares, or create, authorize or issue any obligation or security convertible into or evidencing the right to purchase such equity shares.
However, we may create additional classes of parity equity shares and junior equity shares, amend or supplement our charter to increase
the authorized number of shares of parity equity shares (including the shares of Series A Preferred Stock) and junior equity shares and
issue additional series of parity equity shares and junior equity shares without the consent of any holder of Series A Preferred Stock.

In addition, the affirmative vote or written consent
of the holders of at least two-thirds of the outstanding shares of Series A Preferred Stock and each other class or series of parity preferred
stock with like voting rights (voting together as a single class) is required for us to amend, alter or repeal any provision of our charter,
whether by merger, consolidation or otherwise, so as to materially and adversely affect the voting rights, powers or preferences of the
Series A Preferred Stock, unless the Series A Preferred Stock remains outstanding without the terms thereof being materially adversely
changed in any way adverse to the holders thereof or is converted into or exchanged for preferred stock of the surviving entity having
preferences, conversion and other rights, voting powers, restrictions, limitations as to dividends, qualifications and terms and conditions
of redemption thereof that are substantially similar to those of the Series A Preferred Stock. If such amendment to our charter disproportionately
affects the terms of the Series A Preferred Stock relative to the terms of one or more other classes or series of parity preferred stock,
the affirmative vote or written consent of the holders of at least two-thirds of the outstanding shares of Series A Preferred Stock (voting
separately as a class) is required.

| 12 |

In any matter in